To overcome the many challenges associated with pediatric and patient-centric drug development, Capsugel is offering a new generation of technologies for product development that combines the benefits and flexibility of multi-particulate formulations, lipid-based technologies, and capsule delivery. Proprietary Lipid Multi-Particulate (LMP) technology offers a range of functionality (taste / odor masking, bioavailability enhancement, controlled release, ...) applicable to many formulation challenges. Combined with Coni-Snap® sprinkle capsules, specifically designed to be easily opened in order to allow drugs to be taken in soft foods, LMP technology can offer premier performance in pediatric formulations.
Speaker:
Richard Hart, Business Development Manager, EMEA - Capsugel
Moderator:
Catherine Lehmann, Senior Marketing Manager, EMEA - Capsugel
See the webinar here:
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.